Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

COX-2 inhibitor reported by Searle

April 12, 1996

Senju reports tocopherol derivatives

April 12, 1996

T cell receptor vaccine effective in MS

April 12, 1996

ABT-089 candidate drug for Alzheimer's disease

April 12, 1996

Neruocrine Biosciences, Ciba-Geigy ally for MS research

April 12, 1996

Carbonic anhydrase inhibitor tested for parkinsonism

April 12, 1996

Genentech to develop neurturin for neurodegenerative disorders

April 12, 1996

Genetic markers for manic depression discovered

April 12, 1996

Atypical antipsychotics from Spanish university

April 12, 1996

Generic fluoxetine available in Canada

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...